These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3103207)

  • 1. Selection of beta-lactamase producers during cephalosporin and penicillin therapy.
    Wiedemann B
    Scand J Infect Dis Suppl; 1986; 49():100-5. PubMed ID: 3103207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro action of new beta-lactams on hospital strains of Pseudomonas aeruginosa producing beta-lactamases ].
    Moillo-Batt A; Shacoori ZT
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):510-2. PubMed ID: 6812004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a disk approximation test of inducible beta-lactamases in Enterobacteriacae and Pseudomonas aeruginosa.
    Thore M; Jalakas K; Eriksson I; Dornbusch K
    APMIS; 1989 Apr; 97(4):317-24. PubMed ID: 2497754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal beta-lactam resistance in enterobacteria.
    Normark S; Lindquist S; Lindberg F
    Scand J Infect Dis Suppl; 1986; 49():38-45. PubMed ID: 3547624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of ceftazidime on enterobacteria and Pseudomonas producers of beta-lactamases].
    Chabbert YA; Derlot E; Courvalin P
    Pathol Biol (Paris); 1985 Sep; 33(7):758-63. PubMed ID: 3936006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of beta-lactamase production and resistance to beta-lactam antibiotics in Enterobacteriaceae.
    Cullmann W; Flensberg T; Opferkuch W; Stieglitz M; Wiedemann B
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Sep; 252(4):480-9. PubMed ID: 6758422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors that influence the evolution of beta-lactam resistance in beta-lactamase-inducible strains of Enterobacter cloacae and Pseudomonas aeruginosa.
    Aronoff SC; Shlaes DM
    J Infect Dis; 1987 May; 155(5):936-41. PubMed ID: 3104483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of cefpirome against beta-lactamase-inducible and stably derepressed Enterobacteriaceae.
    Binfiglio G; Stefani S; Nicoletti G
    Chemotherapy; 1994; 40(5):311-6. PubMed ID: 7956454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cephalosporin resistance in Pseudomonas aeruginosa, with special reference to the proposed trapping of antibiotics by beta-lactamase.
    Livermore DM; Williams JD; Davy KW
    Chemioterapia; 1985 Feb; 4(1):28-35. PubMed ID: 3921264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
    Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activity and beta-lactamase stability of cefotetan compared to other beta-lactam antibiotics.
    Neu HC; Chin NX
    Chemioterapia; 1985 Aug; 4(4):271-7. PubMed ID: 3876887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility to penicillins and cephalosporins in beta-lactamase producing strains of E. coli and relative amount of beta-lactamase produced from these strains.
    Normark S; Grundström T; Bergström S
    Scand J Infect Dis Suppl; 1980; suppl 25():23-9. PubMed ID: 7010537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of enzymatic mechanisms of resistance among beta-lactam antibiotics.
    Gutmann L; Kitzis MD; Acar JF
    J Int Med Res; 1990; 18 Suppl 4():37D-47D. PubMed ID: 2126509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antibacterial activity of a new cephalosporin, FR295389, against IMP-type metallo-beta-lactamase-producers.
    Takeda S; Ikeda F; Hatano K
    J Antibiot (Tokyo); 2008 Jan; 61(1):36-9. PubMed ID: 18305358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of genetic determinants involved in beta-lactam- and multiresistance in a surgical ICU.
    van Loon HJ; Box AT; Verhoef J; Fluit AC
    Int J Antimicrob Agents; 2004 Aug; 24(2):130-4. PubMed ID: 15288311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of extended spectrum beta lactamases production with cephalosporin resistance in gram negative bacilli.
    Ghatole M; Manthalkar P; Kandle S; Yemul V; Jahagirdar V
    Indian J Pathol Microbiol; 2004 Jan; 47(1):82-4. PubMed ID: 15471144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-lactamase producing Pseudomonas aeruginosa in hospitalised patients.
    Pandey A; Malenie R; Asthana AK
    Indian J Pathol Microbiol; 2005 Oct; 48(4):530-3. PubMed ID: 16366119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.